Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial

dc.contributor.author	Gómez-Reino Carnota, Juan Jesús
dc.date.accessioned	2017-06-07T07:13:52Z
dc.date.available	2017-06-07T07:13:52Z
dc.date.issued	2013
dc.identifier.issn	0003-4967
dc.identifier.uri	http://hdl.handle.net/20.500.11940/4076
dc.language.iso	eng
dc.title	Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial
dc.type	Artigo	es
dc.authorsophos	Zimmer, R
dc.authorsophos	Scherbarth, HR
dc.authorsophos	Rillo, OL
dc.authorsophos	Gomez-Reino, JJ
dc.authorsophos	Muller, S
dc.identifier.doi	10.1136/annrheumdis-2012-202460
dc.identifier.isi	325532200018
dc.identifier.pmid	23172751
dc.identifier.sophos	14016
dc.issue.number	11
dc.journal.title	Annals of the rheumatic diseases
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Reumatoloxía
dc.page.initial	1830
dc.page.final	1835
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	72

Files in this item

Files	Size	Format	View
There are no files associated with this item.